Drugs / Ybritumomab Tiuxetan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00646750 | Jan 2008 → Feb 2010 | non-Hodgkin lymphoma | Spanish Lymphoma Cooperative Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ybritumomab Tiuxetan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00646750 ↗ |
| Known as | Ybritumomab Tiuxetan (Zevalin) | “Ybritumomab Tiuxetan (Zevalin)” NCT00646750 ↗ |